Premium
Domiciliary non‐invasive ventilation post lung transplantation
Author(s) -
Kotecha Sakhee,
Buchan Catherine,
Parker Kerry,
Toghill Jo,
Paul Eldho,
Miller Belinda,
Naughton Matthew,
Snell Gregory,
Dabscheck Eli
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13160
Subject(s) - medicine , lung transplantation , ventilation (architecture) , lung , intensive care medicine , transplantation , surgery , mechanical engineering , engineering
Background and objective The benefits of domiciliary non‐invasive ventilation ( NIV ) post lung transplantation ( LTx ) have not previously been described. This was a single‐centre retrospective audit of patients requiring domiciliary NIV post‐ LTx . Our aim was to describe indications for NIV and outcomes in chronic lung allograft dysfunction ( CLAD ) and diaphragmatic palsy. Methods All patients requiring domiciliary NIV post‐ LTx between 2010 and June 2016 were assessed. NIV indications, respiratory function and patient outcomes were collected. Results Out of 488 LTx recipients, 20 patients were identified as requiring NIV over the 6.5‐year study period. The most common indications for NIV were CLAD and diaphragmatic palsy. Hypercapnia improved significantly with NIV . Patient outcomes were poor with nine (45%) patients dying, four (20%) undergoing redo‐ LTx , four (20%) continuing domiciliary NIV and only three (15%) patients weaned off NIV . Conclusion This is the first case series to describe the use of domiciliary NIV post‐ LTx . Patients commenced on NIV post‐ LTx had severely impaired lung function and severe hypercapnia. Patients with diaphragmatic palsy often recovered. The mortality rate was high in chronic allograft dysfunction.